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Abstract: Rabbit haemorrhagic disease virus 2 (RHDV2) emerged recently in several European countries, 
leading to extensive economic losses in the industry. In response to this new infection, specific inactivated 
vaccines were developed in Europe and full and rapid setup of protective immunity induced by vaccination 
was reported. However, data on the efficacy of these vaccines in an ongoing-infection scenario is unavailable. 
In this study we investigated an infected RHDV2 indoor industrial meat rabbitry, where fatalities continued to 
occur after the implementation of the RHDV2 vaccination, introduced to control the disease. The aim of this 
study was to understand if these mortalities were RHDV2-related, to discover if the dead animals showed any 
common features such as age or time distance from vaccination, and to identify the source of the outbreak. 
Anatomo-pathological analysis of vaccinated animals with the virus showed lesions compatible with systemic 
haemorrhagic disease and RHDV2-RNA was detected in 85.7% of the animals tested. Sequencing of the 
vp60 gene amplified from liver samples led to the recognition of RHDV2 field strains demonstrating that after 
the implementation of vaccination, RHDV2 continued to circulate in the premises and to cause sporadic 
deaths. A nearby, semi-intensive, RHDV2 infected farm belonging to the same owner was identified as the 
most probable source of the virus. The main risk factors for virus introduction in these two industries were 
identified. Despite the virus being able to infect a few of the vaccinated rabbits, the significant decrease in 
mortality rate observed in vaccinated adult rabbits clearly reflects the efficacy of the vaccination. Nonetheless, 
the time taken to control the infection also highlights the importance of RHDV2 vaccination prior to the first 
contact with the virus, highly recommendable in endemic areas, to mitigate the infection’s impact on the 
industry.
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INTRODUCTION
Both rabbit haemorrhagic disease virus 2 (RHDV2) and rabbit haemorrhagic disease virus (RHDV) are classified within 
the Lagovirus genus along with the genetically related European brown hare syndrome virus (EBHSV)(Capucci et al., 
1991; Le Gall-Reculé et al., 2013). RHDV2 was first reported in 2010 (Le Gall-Reculé et al., 2011), whereas classic 
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RHDV strains have circulated worldwide since 1984 (Nowotny et al., 1997; Capucci et al., 1998; Le Gall et al., 1998; 
Le Gall-Reculé et al., 2003).
Although rabbit haemorrhagic disease (RHD) was first described in China during the 1980s in Angora rabbits that 
had been imported from Germany, the virus is thought to have originated in Europe (Liu et al., 1984). It causes a 
lethal and contagious disease which presents with liver necrosis, splenomegaly and haemorrhagic lesions in the 
liver and in the lungs (Capucci et al., 1991; Marcato et al., 1991). Typically, diseased animals present with fever 
(>40°C), and death occurs rapidly within 12 to 36 h after exposure (Capucci et al., 1991; Marcato et al., 1991; 
McIntosh et al., 2007). Common clinical signs include a blood-tinged foamy nasal discharge, severe respiratory 
distress and/or convulsions, usually preceding death (Marcato et al., 1991; McIntosh et al., 2007). Mortality rates 
are high, ranging from 80% to 100% (Marcato et al., 1991; Ohlinger et al., 1993).
RHDV2, also known as RHDVb, is closely related to RHDV but also highly genetically distinctive and therefore 
represents a new genotype (Le Gall-Reculé et al., 2011, 2013). After its emergence in France (Le Gall-Reculé et al., 
2011), it quickly spread to other European countries (revised in Duarte et al., 2015a), replacing the classic strains 
previously circulating in France (Le Gall-Reculé et al., 2013), the Iberian Peninsula (Bárcena et al., 2015; Calvete 
et al., 2014; Dalton et al., 2014; Lopes et al., 2015) and the Azores (Duarte et al., 2015a). RHDV2 was also reported 
in an isolated case in Australia (Hall et al., 2015). In addition to the European rabbit, RHDV2 is able to infect a few 
hare species (Puggioni et al., 2013; Camarda et al., 2014).
RHDV2 is less virulent than RHDV, and therefore associated with lower mortality rates (Le Gall-Reculé et al., 2013). 
The disease developed also differs from that induced by RHDV in its clinical presentation, given that chronic and 
sub-acute forms are more frequent in RHDV2 infections (Le Gall-Reculé et al., 2013) whereas in RHDV infections 
only a small percentage of animals (5 to 10%) develop a sub-acute or chronic illness presenting with jaundice, 
malaise, weight-loss and death within 1 to 2 wk after the onset of symptoms (McIntosh et al., 2007).
Nestlings as young as 11 d old are susceptible to RHDV2 and develop the disease (Dalton et al., 2012), unlike 
in the case of RHDV, to which kits up to 4 wk of age are naturally resistant (Liu et al., 1984). Regardless of age-
independent susceptibility, the lack of cross protection induced by previous contact with RHDV strains contributed 
to the rapid spread of RHDV2 in Europe (Le Gall-Reculé et al., 2013), resulting in high mortality rates among wild 
populations soon after its emergence.
In the industry, RHDV2 was reported for the first time in France (Le Gall-Reculé et al., 2011), and soon after in 
Great Britain (Baily et al., 2014; Westcott et al., 2014) and the Iberian Peninsula (Dalton et al., 2012; Duarte et al., 
unpublished results), resulting in severe losses in this sector. RHDV-vaccinated rabbits are totally protected against 
RHDV infection but only partially to RHDV2. Hence, in farms with no RHDV vaccination in place the mortality rates 
induced by RHDV2 rose to 80%, while in vaccinated animals the rate observed was considerably lower (25%) (Le 
Gall-Reculé et al., 2013). Still, the limited cross protection against RHDV2 conferred by inactivated or recombinant 
RHDV vaccines (Torres et al., 2000; Le Gall-Reculé et al., 2011, 2013; Dalton et al., 2014) led to the development 
of specific RHDV2 inactivated vaccines in Europe (Filavac VHD Variant, Filavie Laboratories, Cunipravac RHD variant, 
Hipra; Novarvilap, Ovejero). These vaccines were provisionally allowed in the European Union member states, as 
their use requires special licenses from the Local Veterinarian Authorities, and vaccination against RHDV2 has 
become common practice in the industry.
The full and rapid setup of RHDV2 protective immunity induced by Filavac VHD Variant vaccine, established within 
one week, was reported in four- and 10-wk old rabbits (Minor et al., 2013). No cross protection against the classic 
virus was observed (Le Minor et al., 2013). However, there is no data available on the use of vaccination in an 
ongoing-RHDV2 infection scenario.
In this study, we investigated a series of fatalities that occurred in an indoor industrial meat rabbitry after the 
implementation of the RHDV2 vaccination. To clarify the cause of the fatalities, we gathered and integrated clinical, 
epidemiologic, anatomo-histopathologic, virologic and bacteriologic data. After the identification and molecular 
characterisation of RHDV2 as the etiological agent, the research focused on detection of the probable infection 
source, transmission routes and the identification of possible reasons for infection recurrence after vaccination. Our 
data allow preliminary conclusions on the efficacy of vaccination as a therapeutic measure.
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MATERIALS AND METHODS
Sample origin and epidemiological inquiry
A total of twenty-one dead rabbits were analysed. Nine rabbits had not been vaccinated and 12 were vaccinated 
once or twice against RHDV2.  Fourteen of these 21 animals originated from the indoor, semi-intensive, meat 
rabbitry investigated in this study, located in the north of Portugal, hereby referred to as cv-Farm due to its controlled 
ventilation system. The other 7 samples originated from a second industrial farm, located 300 m away, referred to 
as nv-Farm, given its natural ventilation. The casualties occurred between January 2015 and August 2015 (Table 1). 
The cadavers or organs were received at a private laboratory, Segalab, S.A., and then sent to the Instituto Nacional 
de Investigação Agrária e Veterinária (INIAV).
An inquiry was carried out to gather information at the cv-Farm facilities, its operating system, production rates, 
reproductive strategies, prophylactic measures, and, regarding the 21 specimens’ age, immunisation profile and 
vaccination date, time of death, and necropsy data (if performed at the rabbitry). Information on the overall mortality 
among adults and kits was also collected. Cases were numbered according to their chronological occurrence.
Anatomo-histopathological examination
Necropsies were performed by the veterinarian assistant at the rabbitry or by the pathologists at the Pathology 
Laboratory, INIAV.
For anatomo-pathological examinations, liver and lung samples were fixed in 10% buffered formalin and embedded in 
paraffin using standard procedures. Five micrometre-thick sections were stained with haematoxylin and eosin (H&E) 
and examined using light microscopy (Cook, 1997).
Bacteriological analysis
Liver and lung samples from the 21 animals were analysed using standard bacteriological methods, and the presence 
of Pasteurella sp., which is to be considered in the differential diagnosis of RHD according to the OIE (World Organisation 
for Animal Health (OIE) Technical disease cards, 2015), was investigated. Lung and liver sample macerates were 
inoculated in MacConkey agar (Oxoid) and Colombia agar (Oxoid), supplemented with 5% of defibrinated sheep blood 
(Biomerieux) and incubated at 37°C for 24-48 h. Identification of isolates was performed using the commercial API® 
test strips API 20 NE and API ID32 E (BioMérieux). To infer the sanitary status of the animals, which is a public health 
concern as they are used for human consumption, the presence of verocytoxin (VT) producing Escherichia coli strains 
(VTEC) was investigated by multiplex PCR (Paton and Paton, 1998). E. coli strains ED647 (E. coli 0157, vt1, vt2, eae) 
and ED378 (018ab, vt2f ), provided by the European Reference Laboratory for VTEC, Instituto Superiore di Sanitá Italy, 
were used as positive controls and E. coli strain JM109 as a negative control.
Virological examination
Tissue samples comprising liver and lungs were homogenised with phosphate buffered saline (PBS) and clarified 
at 3000  g for 5  min. DNA and RNA were extracted from 200  µL of the clarified supernatant, corresponding to 
approximately 50 mg of tissue, in a BioSprint 96 nucleic acid extractor (Qiagen, Hilden, Germany) according to the 
manufacturer’s instructions.
With regard to vaccines, RNA from vaccine Cunipravac RHD variant (Hipra, Spain) was extracted from the aqueous 
phase of a centrifuged sample (10000 g for 10 min), using the RNeasy blood and tissue kit (Qiagen, Hilden, Germany) 
according to the recommendations. RNA from vaccine Novarvilap (Ovejero, Spain) was extracted from 200 μL of 
a 10×  diluted sample (v/v in bidistilled H20), in a BioSprint 96  nucleic acid extractor (Qiagen, Hilden, Germany) 
according to the manufacturer’s instructions.
Samples were tested for RHDV2  by RT-qPCR (Duarte et  al., 2015b). Screening for RHDV was performed by 
sequencing analysis of the amplicons obtained by conventional PCR with primers RC-9 and RC-10  (Tham et al., 
1999). Conventional RT-PCR and RT-qPCR were performed using the One Step RT-PCR kit (Qiagen, Hilden, Germany).
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The presence of myxoma virus was examined by qPCR (Duarte et al., 2014), using the FastStart TaqMan Probe Master 
Kit (Roche, Roche Diagnostics GmbH, Manheim, Germany).
Cq (quantification cycle) values are inversely related to the concentration of nucleic acid in the sample (revised 
by (Gullett and Nolte, 2015)). For the real time PCR systems described, undetectable Cq or Cq values >40 were 
considered negative.
Nucleotide sequencing analysis
Amplification of the vp60 sequences of RHDV2 strains was accomplished with 2  pairs of primers, 
27F (5’-CCATGCCAGACTTGCGTCCC-3’) and 986R (5’-AACCATCTGGAGCAATTTGGG-3’), 717F 
(5’-CGCAGATCTCCTCACAACCC-3’) (Duarte et  al., 2015a), and RC10R (Tham et  al., 1999) enabling us to obtain 
2  overlapping fragments. The One Step (Qiagen, Hilden, Germany) kit was used, following the manufacturers’ 
recommendations. Sequencing was accomplished using the BigDyeTM Terminator cycle sequencing kit (Applied 
Biosystems, Foster City, CA, USA).
The vp60 nucleotide sequences of 7 complete and 1 partial RHDV2 strains (GenBank accession numbers KU665594 
to KU665601) were determined in an automated 3130 Genetic Analyzer system (Applied Biosystems, Foster City, 
CA, USA).
Nucleotide diversity (π), and its corresponding variances (Nei, 1987) were estimated independently for each sub-
population (nv-Farm and cv-Farm strains) as well as for both sub-populations combined, resorting to DNASP software 
(Version 5.10.01) (Rozas et al., 2003). Standard errors (SE) of each measure were based on 1000 bootstrap replicates. 
DnaSP was also used to calculate the minimum number of recombination events (Rm) in the sample (Hudson and 
Kaplan, 1985).
RESULTS
Insights from the epidemiologic inquiry 
The inquiry revealed that the animals originated from a high-standard rabbitry (cv-Farm) holding 800 does which 
produce around 6000 animals per productive cycle. Does, weighing between 3.5 and 4.5 kg, give birth every 42 d as 
artificial insemination is practiced 11 d postpartum, producing an average of 22 kg of meat per inseminated doe. The 
cv-Farm comprises separate areas for artificial breeding and fattening, and works in a closed, all-in-all-out system, 
with controlled temperature (22 to 26°C), humidity, artificial light and ventilation. Kits are weaned at 32 d of age, at 
which point the mothers are moved to a contiguous area where the next productive cycle begins. Fattened rabbits 
are collected for slaughtering at 70 d of age. Facilities are disinfected by a specialised company and kept empty for a 
week before the following breeding cycle. We also found out that a second semi-intensive farm (nv-Farm), belonging 
to the same owner, is located 300 metres away from the cv-Farm. Both farms are sited on agricultural land. No 
movement of animals was carried out between farms, but sharing of workers was identified.
Epidemiological data linking the farms is schematised in Figure 1.
Regarding the prophylactic measures in practice prior to RHDV2 introduction, it was disclosed that disease control 
was carried out by the veterinary assistant according to an established programme. RHDV vaccination (Arvilap) was 
carried out twice a year (spring and autumn), and Myxoma virus vaccination (MYXV) (Mixohipra H, Hipra) every 4.5 mo. 
Control of internal parasites is achieved by administering albendazole, levamisole, or fenbendazole, alternately, every 
other productive cycle. Insecticides are regularly used for mosquito control. Other preventive sanitary prophylactic 
measures include rodent and plague control by a certified company, which periodically monitors the installed devices 
(such as bait boxes with raticide). Ventilators are sited far from the communication doors and thus from any contact 
with the slaughter and food vehicles as well as the entries through which the animals enter and exit. In addition, 
cadavers are collected 2 km away from the farm by a specialist company, so that this vehicle does not approach 
the farm’s surrounding area. There are no specific nets to avoid contacts with wild rabbits. All the farm workers use 
specific equipment and visitors are not allowed.
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The events started in late October 2014, when a series of deaths were registered in the cv-Farm, with mortalities of 
80% in juveniles and 30-40% in does (Case 1, adult female), respectively. The enquiry revealed that a week earlier, 
several animals of all ages had begun to die in the nv-Farm (Case 0, adult female). RHDV2 presence was confirmed 
in both farms by laboratory diagnosis and, RHDV2 vaccination of the adult females was implemented with Novarvilap 
(Ovejero Laboratories).
Two months later, in January 2015, 2 pregnant females from the cv-Farm, which had been vaccinated 68 d earlier, 
died suddenly without any clinical signs of disease (cases 2 and 3, Table 1). Macroscopic examination of these rabbits 
revealed good body condition, but haemorrhages in the lungs, icteric liver and splenomegaly, raising the suspicion 
of RHD. RHDV2 was confirmed by laboratorial diagnosis. A second RHDV2 outbreak was observed in the cv-farm in 
late February to early March. Newly weaned 27 d-old kits and 35 and 60 d-old rabbits were affected, most of which 
were offspring of primiparous females vaccinated once, 121 d prior. Adults also fell victim and lesions compatible with 
haemorrhagic disease were observed in a few females vaccinated 121 d earlier (cases 5 and 6, Table 1).
Figure 1: Top, schematic representation of the epidemiological context of the farm. Bottom, information on the 
RHDV2-positive sampling with regards to farm of origin, date of collection and vaccination. Black arrows represent 
geographical distances (not in scale). White arrows represent the possible origin and dissemination paths. Risk factors 
are shown within grey boxes. Numbers in brackets refer to case numbers, which position in relation to the calendar 
(on the left) refers to time of death. The case numbers corresponding to vaccinated rabbits are underscored. AF, 
adult females; FR, fattening rabbits; nv-Farm, natural ventilated farm; cv-Farm, controlled ventilated farm. Vaccines 
are represented by triangles (black, Novarvilap; grey, Cunipravac RHD variant). *Strains with vp60 gene sequenced.
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Limitations from the supplier led to the introduction of a second RHDV2 vaccine (Cunipravac RHD variant, Hipra, 
Spain) in both farms at the beginning of March and the enquiry revealed that a few weaned kits were also vaccinated 
once with this vaccine.
The last mortalities in the cv-Farm occurred in mid-late March, affecting vaccinated females (cases 7, 8, 13, 
Table 1), including one multiparous that had given birth recently (case 7) and another pregnant multiparous (case 8). 
Females 7 and 8 had been vaccinated twice, with the Norvavilap and Cunipravac RHD variant, 138 and 15 d before, 
respectively. Female 13 was vaccinated once with the Cunipravac RHD variant, 27 d before. Thirty-five-day old kits, 
vaccinated once with the Cunipravac RHD variant (cases 9, 10, 11, Table 1), also fell victim.
In the nv-Farm, mortalities due to RHDV2 continued to occur until late July 2015, affecting non-vaccinated fattening 
kits aged 35 to 70 d (cases 15-19, Table 1). No more casualties were observed thereafter. 
Microbiology
RHDV2 was detected in 18 of the 21 rabbits analysed (Cases 0-3, 5-13, 15-19, Table 1, and Figure 2), by RT-qPCR 
(Duarte et al., 2015b). Viral loads were variable, as Cq values ranged from 9.53 to 36.14, with high viral charges 
(Cq<25) found in the majority of the samples tested (n=13/18, 72.22%). Despite the limited sampling, a positive 
association was observed between viral loads and lesion severity in kits (Figure 2).
Only 3 out of the 21  animals analysed were negative for RHDV2  (cases 4, 14  and 20, Table 1). Data of 
the 18  RHDV2-positive cases, regarding sample origin, collection and vaccination date, are represented in 
Figure 1 (bottom).
Figure 2: Viral charges found in RHDV2-positive samples. Circles represent adults and triangles the young. Colour 
corresponds to samples where microscopic lesions were observed (black), not determined (grey) or absent (white). 
Viral charges were inferred from the respective Cq values according to the regression equation published by Duarte 
et al., 2015b. Cq values are shown above the symbols. Cases 4, 14 and 20 (RHDV2-negative) are not represented.
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Pasteurella multocida was isolated from the lungs of one RHDV2-negative multiparous doe (case 4). Neither 
Salmonella, Yersinia, Staphylococcus nor Listeria were detected. E. coli was isolated from the tissues of 3  adult 
females (cases 5, 6 and 7) and 3 kits (cases 9, 10 and 11), all RHDV2-positive rabbits, but no associated virulence 
genes (vtx1, vtx2, eae and vtx2f) were found.
Anatomo-histopathology
No signs of disease were registered prior to death in any of the 21 rabbits. Bloody discharges from the nose, observed 
in 5 animals (23.81%, case 4 [RHDV2-negative], and cases 7, 9, 10 and 11, all RHDV2-positive), were the only 
outward manifestation of an ongoing pathology.
Macroscopically, in the RHDV2 positive animals, an icteric liver and hepatomegaly were the most common lesions 
(90 to 100%) followed by lung petechiae (45 to 50%) and moderate splenomegaly (30%). Hepatic discoloration was 
also observed (cases 9, 10 and 11, all referring to RHDV2 positive kits).
At microscopic level, the great majority of the lesions in the RHDV2-positive rabbits matched the typical RHD 
lesions described above (Ohlinger et al., 1993). Those included microfoci of hepatic necrosis, detected in the liver 
parenchyma of 6 animals (cases 9-12, 16 and 17, all RHDV2-positive; cases 9-11 and 17 vaccinated, and cases 
12 and 16 not vaccinated). Hepatocyte hyalinisation was found in 5 of these samples (cases 9-11, 16 and 17). Lung 
histopathology was performed in 2 specimens showing severe congestion and disseminated intravascular coagulation 
in the small capillaries (cases 9 and 10).
In the adult female case 4, lesions consisted of purulent pneumonia with extensive parenchymal infiltration by 
inflammatory cells, mainly neutrophils, and occasional bacteria clumps associated with necrotic foci.
Despite some degree of autolysis, no lesions were recognised in the liver or lungs of the adult rabbit case 13, where 
a RHDV2 high Cq value (36.14) was obtained.
Insights from the molecular analysis
Similarity among field strains was above 99.43%, with 2 of the complete sequences being identical (KU665597 and 
KU665598, Table 2) and 2 differing only in 1 nucleotide (KU665595 and KU665596, Table 2). The average number 
of nucleotide differences (k) and the nucleotide diversity (π) found among all vp60 sequences showed intermediate 
Table 2: Nucleotide similarity percentage among the vp60 nucleotide sequences of two vaccines and eight field 
RHDV2 strains.
Strains Case 0 Case 1 Case 3 Case 7 Case 10* Case 15 Case 16 Case 17 Vaccine A Vaccine B
Case 0# - 100 99.60 99.83 99.90* 99.89 99.83 99.83 98.74 97.82
Case 1† - 99.60 99.83 99.90* 99.89 99.83 99.83 98.74 97.82
Case 3† - 99.43 99.18* 99.48 99.54 99.54 98.91 97.76
Case 7† - 99.90* 99.83 99.77 99.77 98.56 97.64
Case 10†* - -* 99.80* 99.80* 98.17* 97.66*
Case 15# - 99.83 99.83 98.62 97.70
Case 16# - 99.94 98.68 97.64
Case 17# - 98.68 97.64
Vaccine A - 97.82
Vaccine B -
Strains are referred by the case number.
*Similarities based on a partial vp60 sequence (981bp long). Vaccines’ identification is restrained for privacy. 
#Lines highlight samples from the semi-intensive farm. 
†Lines correspond to samples originated in the industrial farm. 
GenBank accession numbers: Case 0 (KU665601), Case 1 (KU665600), Case 3 (KU665598), Case 7 (KU665597), 
Case 10 (KU665599), Case 15 (KU665594), Case 16 (KU665596), Case 17 (KU665595).
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values (k:3.333, π:0.00340) when compared with the homologous figures obtained independently from the strains of 
the nv-Farm (k:2.66667, π:0.00153) and the cv-Farm (k:4.667, π:0.00476).
Interestingly, one recombination event (Rm) was detected between nucleotide sites 1272  and 1416, based on 
45 pair-wised comparisons of the 7 complete sequences. When analysed independently, no recombination events 
were detected in any of the 2 sub-populations of sequences.
As expected, at the polypeptide level the variability was lower. All strains originating from the 2 farms exhibited a 
common polymorphism involving Ile347, not shared by the 2 vaccines.
DISCUSSION
RHDV2  RNA was detected in most of the rabbits analysed as 18  (87.5%) of the 21  animals investigated were 
RHDV2-positive. Vaccine RNA was not identified in any of the tissue samples from which viral RNA was amplified and 
sequenced. Field strains showed clear nucleotide discrepancies with regard to the sequences of the 2 inactivated 
vaccines (Carvalho et al., 2017) used. None of the 21 rabbits was positive to classic RHDV, in consonance with the 
notion that RHDV2 has been replacing the classic RHDV strains in wild and domestic rabbit populations of the Iberian 
Peninsula (Lopes et al., 2015).
The majority of the dead animals did not show any clinical sign of illness and were in good body condition at the 
necropsy, which is consistent with an acute disease and sudden death. This finding contrasts with other reports 
stating that RHDV2 induces a more prolonged disease when compared to RHDV (Le Gall-Reculé et al., 2013; Puggioni 
et al., 2013), resulting in progressive but extensive liver damage that precedes death. The high level of pathogenicity 
of the circulating strains is also supported by the elevated mortality rates observed in adults (30-40%) and kits (80%), 
clearly above the values reported previously in RHDV vaccinated/RHDV2 non-vaccinated farms (up to 20% for adult 
and 50% for kits (Dalton et al., 2012)).
The macroscopic lesions showed that the lungs and liver were the most affected organs, also in agreement with 
earlier descriptions (Dalton et al., 2012; Duarte et al., 2015a; Lopes et al., 2015).
Pasteurella multocida, a gram-negative, non-motile Coccobacillus, was isolated from the lungs of a RHDV2-negative 
multiparous doe (case 4). Pasteurellosis, a highly contagious disease transmitted either by direct contact or by 
aerosols, was not detected in any of the other victims, indicating that this disease was neither related to the serial 
deaths, nor spread through the rabbitry. The source of this single case was not identified.
No possible cause of death was recognised for the other 2 RHDV2-negative rabbits (cases 14 and 20, Table 1), as 
none of the tested pathogens was detected.
Given that the disease was detected 1 wk earlier in the nv-Farm, it is likely that the virus spread from there into the 
neighbouring cv-Farm. The proximity and the sharing of some employees most likely contributed to the dissemination 
of the virus from the nv-Farm into the cv-Farm. The 100% similarity between the 2 strains obtained in October 2014, 
when the first cases occurred (case 0  from the nv-Farm, case 1  from the cv-Farm, Table 2), provides molecular 
evidence of an epidemiological link between the 2 events. This is also corroborated by the lack of diversity between 
these 2 strains and the strains that circulated in both farms between January and April 2015  (99.69 to 99.90% 
nucleotide similarity), as well as by the reduced variability observed amongst the strains that circulated later in the 
farm in 2015 (similarities ranging from 99.43 to 99.94%). The nucleotide variability observed (<0.57%) is below 
the average value (1.3%) previously described among strains originating from different farms (Le Gall-Reculé et al., 
2013). The genetic diversity (π) found among nv-Farm strains (0.00153±0.00044) was significantly lower than in 
the industrial cv-Farm strains (0.00476±0.00192). This may be related to the higher livestock density in the latter, 
which favours a higher transmission rate, resulting in a faster accumulation of mutations. The 8 strains did not exhibit 
any unique or exclusive amino acidic variation that could be clearly linked with its putative higher virulence. However, 
all of them share an Ile at position 347, located in the hyper variable region V2 defined by (Wang et al., 2013). Both 
vaccines present a different residue at this position. In the large majority of the RHDV2 strains characterised so far, 
a Thr was mapped at position 347, though a Val or an Ala have also been identified. It is interesting to notice that 
Ile347 is also present in other Portuguese strains previously characterised as originating in the north, centre and south 
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of mainland Portugal, as well as in the Azores (Duarte et al., 2015a). Most of these strains originated on rabbit farms 
(KJ683896 and Carvalho et al., unpublished results), but no data was available on the mortality rates induced.
A surprising finding of this study was the death of RHDV2-positive animals that had been vaccinated twice (case 7, 
Cq 15.27 and 8, Cq 29.08, Table 1), indicating that those animals developed the disease despite vaccination. On 
the farm, the cold chain for the vaccines is carefully maintained in order to guarantee its preservation. Moreover, all 
vaccination procedures are carried out systematically by the veterinary assistant according to the protocol, ensuring 
that all adult animals are vaccinated and that the correct vaccine dose is administrated. This greatly reduces the 
possibility that lack of vaccination or reduced vaccine dose may have been at the origin of the mortality of the 
vaccinated does. Individual variability to vaccination may have been at the source of those unexpected outcomes. 
In view of the lower mortality rate induced by RHDV2 when compared to RHDV, detection of viral RNA in apparently 
healthy animals that recovered from the infection is expected, as genomic RNA or RNA fragments are known to persist 
for at least 15 wk after experimental infection (Gall et al., 2006, 2007). However, the Cq values of these 2 animals 
are substantially reduced and too low to represent leftovers from previous infections when compared to the range 
previously described for RNA and DNA viruses, namely for the blue tongue virus (BTV) (De Leeuw et al., 2015; Barros 
et al., 2007) and parvoviruses (Duarte et al., 2013). As no animals were sacrificed nor in vivo experiments carried 
out to determine the infectious (viable viral particles) or non-infectious (RNA segments) nature of the RHDV2-RNA, 
this aspect was not clarified in this study. However, interestingly, they showed no lesions in the liver and lungs and 
generated a high Cq value (36.14).
The large majority of the RHDV2  RNA-positive rabbits (17/18, 94.4%), including those with Cq values above 
30.0  (cases 2, 5, 6), showed typical RHDV2 macroscopic lesions. This fact, along with negative results to other 
common viral and bacterial pathogens, strongly suggests that all these fatalities, with the exception of case 4, were 
RHDV2-related.
The death of vaccinated adults indicates that the infection of these animals occurred before an effective immune 
response could be established, or alternatively, that an ongoing infection hampered the development of an effective 
immune protection. Exposure to a highly infectious dose, before the vaccine derived protective immune response was 
fully established, may explain disease development in the adult cases 3 and 7. Despite the virus being able to infect 
a few vaccinated rabbits from the farm, it did not induce clinical disease in most of the adults that died. Macroscopic 
lesions were observed in most of the animals but, as the majority of the organs were received frozen, it was neither 
possible to investigate if typical RHDV2-microscopic lesions were also present in these animals nor to establish a 
relationship between histo-pathological lesions, viral charge and death for all the animals. This would have been 
particularly relevant to evaluate the cause of death of the does with lower viral charges.
The significant decrease in the mortality rate observed in the adults after RHDV2 vaccination, which was null after 
August 2015, compared with the mortality rates observed prior to vaccination (30-40%), exemplified the success of 
vaccination in controlling the disease.
In the RHDV2 infected kits, a positive association was observed between viral load and the severity of the characteristic 
anatomo-pathological lesions found in the liver and lungs. Lower Cq values were observed in vaccinated kits (Table 1), 
suggesting the interference of maternal antibodies with vaccination success, which may have facilitated disease 
progression (Carvalho et al., 2017).
The time gap between vaccination and casualty varied between 15 d (cases 7, 8, 9, 10 and 11, Table 1) and 121 d 
(cases 5 and 6, Table 1). Curiously, no trend could be observed between the time gap between vaccination and the 
Cq value. While no obvious explanation was identified for the lower value of case 3 (Cq 9.53), physiological stress 
due to recent partum and lactation may have accounted for the progression of the infection in female 7 (Cq 15.27).
The molecular investigation revealed that RHDV2  continued to circulate in the premises for a few months after 
vaccination. This could be related to the fact that, at any specific time interval, there was always a subset of 
unvaccinated kits more susceptible to the infection. Infected kits were mostly the offspring of primiparous females, 
which showed an energy deficit due to simultaneous pregnancy, milk production, and growth, and so were expected 
to pass lower limited immunity to their litters.
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Also interesting was the detection of RHDV2-RNA in an early stage foetus from a RHDV2 positive-doe that had been 
vaccinated twice, the last shot administered 15 d before death (results not shown). A Cq value of 34.08 was obtained 
from the foetus (result not shown), higher than the Cq value (29.08) of the mother, which may suggest the RHDV2 is 
able to cross the placenta. However, further investigation is required as well as confirmation to rule out foetus 
contamination with the maternal blood during the uterus opening. To our knowledge, there are no previous reports 
supporting the congenital infection by RHDV (Xu, 1991).
Neither Salmonella, VTEC, Yersinia, Staphylococcus nor Listeria were detected, attesting good sanitary conditions in 
the rabbitry.
Several risk factors for the introduction of RHDV2 in the rabbitry were identified. The rural surroundings of both farms 
may have favoured RHDV2 introduction through indirect contact with infected wild species, namely wild rabbits, as 
no specific protection nets are used. Between 2013 and 2015, a particularly high mortality rate was observed in 
wild rabbits from legal hunting parks (Dr Fidélia Aboim-Municipal Veterinarian, personal communication), the nearest 
located only 5.3 km away from the farms. According to what has been described in many other regions of the country 
since 2012  (Abrantes et al., 2013; Lopes et al., 2015; Duarte et al., 2015b), RHDV2 was most probably at the 
origin of casualties in the wild rabbit population. Therefore, it is possible that RHDV2 transmission occurred from the 
infected hunting populations into the nv-Farm, via fomites, by human means or arthropods. It has been demonstrated 
that mosquitoes from the Culex genus, active in Portugal from spring to autumn (Alves et al., 2014), play a role in 
disease dissemination (McColl et al., 2002). Furthermore, the climatic conditions of the area, which has high levels 
of humidity, create a suitable mosquito habitat.
Likewise, the role of rodents as viral carriers has been supported by the detection of RHDV2 in mammals other than 
rabbits (Merchán et al., 2011). As the farm is located on agricultural land where rodents are abundant, it is also 
important to consider their potential role in the transmission of RHDV2 into the rabbitry, although rodent prophylactic 
measures are carried out.
Another critical point relates to the high resistance of the virus to environmental conditions (Henning et al., 2005). 
The use of transport vehicles often shared by different rabbit farms may have also accounted for the spreading of the 
disease locally and across confluent districts.
CONCLUSIONS
The low nucleotide diversity per site (π:0.00340±0.00132) amongst the vp60 sequences from strains obtained over 
a 6 mo-period was consistent with a common viral source for the 2 farms. The absolute identity between the strains 
obtained in both farms during the initial focuses (KU665601 and KU665600) led to recognition of the nv-Farm as the 
probable source of the virus for the cv-Farm.
Whereas a molecular epidemiological link was established between the 2 farms, no path could be identified as the 
most probable means for the introduction of the virus in the nv-Farm. However, several risk factors were recognised, 
relating to the agricultural land where the farms are located, the high mortality of wild rabbits in hunting parks in the 
same geographic area and the sharing of slaughterhouse vehicles by the rabbitries in the region.
Several months passed before mortality decline was observed following the initiation of vaccination. The time taken 
before herd immunity could be established undoubtedly highlights the importance of vaccination prior to infection. 
Several factors may have accounted for the difficulty in reducing and eliminating the virus circulation from the 
premises, such as the continuous and rapid turnover of the population on intensive farms, which ensures the constant 
availability of susceptible kits from each new productive cycle, facilitating viral persistence. The putative higher 
virulence of the strains, supported by the mortality rates observed prior to vaccination, might have required higher 
antibody titres in the population to impede transmission between animals. No data is known about the immunogenicity 
of inactivated RHDV2 vaccines when applied as a therapeutic tool to infected populations. However, we believe this 
dynamic investigation provides preliminary data on the usefulness of vaccination post-infection. While several of 
these aspects need to be further elucidated, vaccination was proven as an important preventive measure against 
RHDV2 infection, before rabbitries at risk face this infection.
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